The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL	diffuse large B-cell lymphoma, non-Hodgkin lymphoma	Active, not recruiting	Phase 2	2026-09-23		NCT03463057

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Stichting Hemato-Oncologie voor Volwassenen Nederland	27

32 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BE-Antwerpen Edegem-UZA	Antwerp	Belgium	2
BE-Antwerpen-ZNASTUIVENBERG	Antwerp	Belgium	8
BE-Brugge-AZBRUGGE	Bruges	Belgium	6
BE-Leuven-UZLEUVEN	Leuven	Belgium	10
BE-Roeselare-AZDELTA	Roeselare	Belgium	7
NL-Amersfoort-MEANDERMC	Amersfoort	Netherlands	13
NL-Amsterdam-OLVG	Amsterdam	Netherlands	8
NL-Amsterdam-VUMC	Amsterdam	Netherlands	10
NL-Apeldoorn-GELREAPELDOORN	Apeldoorn	Netherlands	3
NL-Breda-AMPHIA	Breda	Netherlands	10
NL-Delft-RDGG	Delft	Netherlands	8
NL-Den Bosch-JBZ	's-Hertogenbosch	Netherlands	14
NL-Den Haag-HAGA	The Hague	Netherlands	13
NL-Dordrecht-ASZ	Dordrecht	Netherlands	14
NL-Ede-ZGV	Ede	Netherlands	6
NL-Eindhoven-CATHARINA	Eindhoven	Netherlands	7
NL-Eindhoven-MAXIMAMC	Eindhoven	Netherlands	11
NL-Enschede-MST	Enschede	Netherlands	11
NL-Groningen-UMCG	Groningen	Netherlands	17
NL-Hilversum-TERGOOI	Hilversum	Netherlands	4
NL-Hoofddorp-SPAARNEGASTHUIS	Hoofddorp	Netherlands	7
NL-Leeuwarden-MCL	Leeuwarden	Netherlands	10
NL-Leiden-LUMC	Leiden	Netherlands	9
NL-Maastricht-MUMC	Maastricht	Netherlands	13
NL-Nieuwegein-ANTONIUS	Nieuwegein	Netherlands	10

Clinical trials